37 results on '"Guan, Xin-Yuan"'
Search Results
2. Ferroptosis: Promising approach for cancer and cancer immunotherapy
- Author
-
Zheng, Shuyue and Guan, Xin-Yuan
- Published
- 2023
- Full Text
- View/download PDF
3. Characterization of oncogene-induced metabolic alterations in hepatic cells by using ultrahigh performance liquid chromatography-tandem mass spectrometry
- Author
-
Tang, Zhi, Cao, Tingting, Lin, Shuhai, Fu, Li, Li, Shangfu, Guan, Xin-Yuan, and Cai, Zongwei
- Published
- 2016
- Full Text
- View/download PDF
4. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma
- Author
-
Yeung, Oscar W.H., Lo, Chung-Mau, Ling, Chang-Chun, Qi, Xiang, Geng, Wei, Li, Chang-Xian, Ng, Kevin T.P., Forbes, Stuart J., Guan, Xin-Yuan, Poon, Ronnie T.P., Fan, Sheung-Tat, and Man, Kwan
- Published
- 2015
- Full Text
- View/download PDF
5. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer.
- Author
-
Bi, Jiong, Lau, Sze-Hang, Lv, Zi-Li, Xie, Dan, Li, Wen, Lai, Ying-Rong, Zhong, Jue-Min, Wu, Hui-qun, Su, Qiao, He, Yu-long, Zhan, Wen-Hua, Wen, Jian-Ming, and Guan, Xin-Yuan
- Subjects
STOMACH cancer ,GROWTH factors ,TUMOR markers ,GENE expression ,CANCER histopathology ,CELLULAR signal transduction ,DIAGNOSTIC immunohistochemistry ,PROGNOSIS - Abstract
Summary: YKL-40 is a growth factor for connective tissue cells and a migration factor for endothelial cells. Elevated serum level of YKL-40 has been associated with poor prognosis in many cancers. However, the status of YKL-40 expression and its clinical/prognostic significance in gastric cancer are unclear. In this study, the expression of YKL-40 was studied by immunohistochemistry in gastric cancer tissue microarray containing 172 primary gastric cancer cases and 70 adjacent nonneoplastic mucosa specimens. The correlations between YKL-40 expression and clinicopathologic features, as well as activation of PI3K/Akt pathways were addressed. Expression of YKL-40 was significantly higher in gastric cancer tissues than that in adjacent nonneoplastic tissues. Overexpression YKL-40 was found in 28.4% of gastric cancers and was significantly associated with tumor invasion (P = .007) and lymph node metastasis (P = .009). For survival study, overexpression of YKL-40 was significantly associated with worse outcome (P = .001). When known clinical variables were added to a multivariate analysis, TNM stage, tumor size, and overexpression of YKL-40 emerged as independent prognostic factors. Further study indicated that the oncogenic function of YKL-40 might be through the activation of Akt pathway. These results suggest that overexpression of YKL-40 is correlated with the aggressive behavior of tumor cells, which could be used as an independent molecular marker for the predicting poor prognosis of patients with gastric cancer. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
6. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma.
- Author
-
Xie, Dan, Ma, Ning-Fang, Pan, Zhi-Zhong, Wu, Hui-Xi, Liu, Yong-Dong, Wu, Guo-Qing, Kung, Hsiang-Fu, and Guan, Xin-Yuan
- Subjects
OVARY abnormalities ,COLON cancer ,IMMUNOHISTOCHEMISTRY ,CELL proliferation - Abstract
Summary: Our previous study has suggested an oncogenic role of eIF-5A2 in ovarian tumorigenesis. Abnormalities of eIF-5A2, however, in colorectal carcinoma are unclear. In this study, amplification and overexpression of eIF-5A2 in colorectal carcinoma were studied by fluorescence in situ hybridization and immunohistochemistry using colorectal carcinoma tissue microarrays, including 139 primary colorectal carcinomas and their adjacent normal mucosa, 22 paired premalignant adenomas, and 42 metastatic tumors. The immunohistochemistry results showed that overexpression of EIF-5A2 was detected in none of normal epithelial mucosa, 35.3% of colorectal adenomas, 53.2% of primary colorectal carcinomas, and 67.6% of metastases. Amplification of eIF-5A2 was detected in 15.8% (16/101) of informative colorectal carcinomas, and most of them showed overexpression of EIF-5A2. In primary colorectal carcinomas, the frequency of EIF-5A2 overexpression was significantly higher in colorectal carcinomas with lymphovascular invasion (61.2%) than that in colorectal carcinomas without lymphovascular invasion (36.6%, P < .05). In addition, significant positive associations were found between EIF-5A2 overexpression and the tumors'' later pN and pM stages, as well as increased tumor cell proliferation (P < .05). These findings suggest that overexpression of EIF-5A2 in colorectal carcinomas may be important in the acquisition of a metastatic phenotype and plays an important role in colorectal carcinoma development and progression. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
7. Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma.
- Author
-
Ma, Stephanie, Guan, Xin-Yuan, Lee, Terence K., and Chan, Kwok Wah
- Subjects
METASTASIS ,PROTEINS ,LIVER cancer ,GROWTH factors - Abstract
Summary: Missing in metastasis (MIM) proteins are important regulators in controlling cell growth and development. There has been accumulating evidence suggesting a role of MIM-B in carcinogenesis, yet its role in the development of hepatocellular carcinoma has not been examined thus far. In this study, we investigated the clinicopathological significance of MIM-B in tumor and its matched adjacent nontumor tissue obtained from 40 patients with hepatocellular carcinoma. Increased MIM-B messenger RNA and protein expression, as detected by quantitative real-time polymerase chain reaction and Western blot, respectively, was found in hepatocellular carcinoma clinical samples; and its expression was significantly associated with early pathologic tumor-node-metastasis stage group (P = .007), presence of tumor encapsulation (P = .034), and absence of venous infiltration (P = .038). Higher levels of MIM-B expression were found to be associated with early stage disease. Elevated MIM-B expression may influence the development of hepatocellular carcinoma and may possibly be a powerful indicator for the disease at an early stage. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
8. Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor Cells.
- Author
-
Ma, Stephanie, Chan, Kwok–Wah, Hu, Liang, Lee, Terence Kin–Wah, Wo, Jana Yim–Hung, Ng, Irene Oi–Lin, Zheng, Bo–Jian, and Guan, Xin–Yuan
- Subjects
LIVER cancer ,ONCOGENIC viruses ,CANCER invasiveness ,STEM cells - Abstract
Background & Aims: Recent efforts in stem cell biology suggest that tumors are organized in a hierarchy of heterogeneous cell populations and that the capability to maintain tumor formation/growth specifically resides in a small population of cells called cancer stem cells (CSCs). The aim of this study is to identify, isolate, and characterize the CSC population that drives and maintains hepatocellular carcinoma (HCC) growth and metastasis. Methods: Normal stem cells involved in liver regeneration were identified using a severe partial hepatectomy model. Purified HCC cells, with or without expression of the identified normal stem cell phenotype, were evaluated, based on their tumorigenic potential and exhibition of defined stem/progenitor cell-like properties, to determine whether liver CSCs can be or partly be identified by this surface marker. Results: We report the identification and isolation of a population of CSCs expressing a CD133 surface phenotype from human liver cell lines. CD133
+ cells possess a greater colony-forming efficiency, higher proliferative output, and greater ability to form tumor in vivo. These cells are endowed with characteristics similar to those of progenitor cells including the expression of “stemness” genes, the ability to self-renew, and the ability to differentiate into nonhepatocyte-like lineages. Furthermore, CD133 is found to represent only a minority of the tumor cell population in human HCC specimens. Conclusions: We report the identification of a CSC population in HCC characterized by their CD133 phenotype. The identification of tumorigenic liver CSCs could provide new insight into the HCC tumorigenic process and possibly bear great therapeutic implications. [Copyright &y& Elsevier]- Published
- 2007
- Full Text
- View/download PDF
9. Significance of TWIST expression and its association with E-cadherin in bladder cancer.
- Author
-
Zhang, Zheng, Xie, Dan, Li, Xin, Wong, Yogn-Chuan, Xin, Dianqi, Guan, Xin-Yuan, Chua, Chee Wai, Leung, Steve C.L., Na, Yanqun, and Wang, Xianghong
- Subjects
TRANSCRIPTION factors ,CADHERINS ,BLADDER cancer ,PATHOLOGY - Abstract
Summary: Recently, TWIST, a basic helix-loop-helix transcription factor, has been reported to play a key role in the metastatic progression of several types of human cancer. The aim of this study was to investigate the significance of TWIST expression in bladder cancer using tissue microassays generated from 226 bladder tissue specimens. Using immunohistochemical staining, we studied TWIST expression levels in nonmalignant bladder tissues (n = 37), primary bladder cancer tissues (n = 164), and 25 cases of matched lymph node metastatic lesions. The association between TWIST expression levels and tumor staging and grading, as well as metastatic potential, was analyzed by statistical analysis. Our results showed that TWIST protein expression was significantly higher in bladder cancer specimens compared with nonmalignant tissues (P < .001), indicating its positive role in the development of bladder cancer. In addition, increased TWIST expression levels were associated with advanced-stage and high-grade tumors, suggesting its involvement in the progression of this cancer. Furthermore, TWIST expression was much higher in the metastatic lesion compared with its primary site (P < .05). More importantly, the increased TWIST expression in bladder cancer specimens was correlated with decreased membranous expression of E-cadherin, a cell adhesion molecule that plays a key role in the metastatic progression of human cancer. Our results demonstrate TWIST as a novel positive factor in the development and progression of bladder cancer and suggest a marker for advanced bladder cancer. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
10. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma.
- Author
-
Xie, Dan, Sham, Jonathan S.T., Zeng, Wei-Fen, Lin, Han-Liang, Bi, Jiong, Che, Li-Hong, Hu, Liang, Zeng, Yi-Xin, and Guan, Xin-Yuan
- Subjects
BREAST cancer ,DNA ,COLON cancer ,GENES - Abstract
Summary: AIB1, a member of the steroid receptor coactivator 1 family, has been cloned on 20q12 and is a candidate oncogene in human breast cancer. It is commonly amplified and overexpressed in several types of human cancers. In this study, we examined the expression of AIB1, as related to clinicopathologic features, in 85 human colorectal cancers (CRCs). The status of the number of AIB1 copies, p53 expression, and DNA ploidy was also analyzed. The overexpression of AIB1 was detected in 35% of CRCs. Amplification of AIB1 was observed in 10% of CRCs. In addition, the overexpression of AIB1 was observed more frequently in CRCs in later clinical stages (T3 N1 M0/T3 N0 2M1), compared with that in T3 N0 M0 stage (P < .05). These results suggest that overexpression of AIB1 might provide a selective advantage for the developmental growth and/or progression of subsets of CRCs. In addition, a significant correlation (P < .05) of overexpression of AIB1 with p53 overexpression as well as with aneuploid DNA content was observed in these CRCs. The overexpression of p53 was also correlated significantly with CRC DNA ploidy (P < .05). Furthermore, there was a substantial population of CRCs showing overexpression of both AIB1 and p53 protein and all had aneuploid DNA content; most of these were in the later clinical stage. These findings suggest a possible convergence of AIB1 with a pathway involving p53, which might induce chromosomal instability and affect the clinical phenotype of a subset of CRCs. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
11. Evidence for another tumor suppressor gene at 17p13.3 distal to TP53 in hepatocellular carcinoma
- Author
-
Guan, Xin-Yuan, Sham, Jonathan S.T., Tai, Lai-Shan, Fang, Yan, Li, Hong, and Liang, Qiwan
- Subjects
- *
LIVER cancer , *HETEROZYGOSITY - Abstract
Loss of 17p is one of the most frequent chromosomal alterations in primary hepatocellular carcinoma (HCC). In the present study, the association between loss of 17p and TP53 mutation was analyzed in 94 primary HCC of Chinese patients. Loss of one allele at 17p13.3 distal to the TP53 gene was observed in 48 of 94 HCC (51%), whereas loss of heterozygosity (LOH) at 17p13.1 near the TP53 gene was detected in 30 of 94 HCC (32%) and TP53 mutation was detected in only 22 of 94 HCC (23%). High frequency of LOH at 17p13.3 and relatively low frequency of TP53 mutation in the present study indicate that loss of function of a putative tumor suppressor gene at 17p13.3 may play a more important role than TP53 in HCC development. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
12. Characterization of a complex chromosome rearrangement involving 6q in a melanoma cell line by chromosome microdissection
- Author
-
Guan, Xin-Yuan, Zhang, Hong-En, Zhou, Hang, Sham, Jonathan S.T., Fung, Jackie M-W., and Trent, Jeffrey M.
- Subjects
- *
MELANOMA , *CHROMOSOMAL translocation , *CHROMOSOMAL rearrangement , *GENETICS - Abstract
Deletion of 6q is one of the most frequent chromosomal alterations in human malignant melanoma. Recently, we used chromosome painting probes of 6p and 6q to study 21 melanoma cell lines. A reciprocal translocation between chromosomes 6q and 17p was detected in one cell line (UACC-930). Upon further characterization of the translocation marker using the micro fluorescence in situ hybridization (FISH) technique, a complex rearrangement including an inversion of 6q and a translocation between the inverted 6q and 17p, [der(6)inv(6)(q16q27)t(6;17)(q26;p13)], was detected. A yeast artificial chromosome (YAC) clone spanning the breakpoint at 6q16 was isolated by the FISH screen. Loss of one or more copies of the YAC clone was also detected in 10 of 12 melanoma cell lines. This result implies that the YAC clone may contain a putative tumor suppressor gene related to the pathogenesis of malignant melanoma. Further characterizations of the breakpoint at 6q16 and molecular cloning breakpoints at 6q27 and 17p13 are in progress. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
13. 773: FGFR2+ fibroblast-derived BMP5 promoted radioresistance in esophageal carcinoma.
- Author
-
WANG, Ying, FENG, Ping, JIANG, Tong chao, ZHU, Yu jia, GUAN, Xin yuan, and XIA, Yun fei
- Subjects
- *
CARCINOMA - Published
- 2024
- Full Text
- View/download PDF
14. PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation.
- Author
-
Chan, Lok Hei, Zhou, Lei, Ng, Kai Yu, Wong, Tin Lok, Lee, Terence K., Sharma, Rakesh, Loong, Jane H., Ching, Yick Pang, Yuan, Yun-Fei, Xie, Dan, Lo, Chung Mau, Man, Kwan, Artegiani, Benedetta, Clevers, Hans, Yan, Helen H., Leung, Suet Yi, Richard, Stéphane, Guan, Xin-Yuan, Huen, Michael S.Y., and Ma, Stephanie
- Abstract
Summary Arginine methylation is a post-translational modification that plays pivotal roles in signal transduction and gene transcription during cell fate determination. We found protein methyltransferase 6 (PRMT6) to be frequently downregulated in hepatocellular carcinoma (HCC) and its expression to negatively correlate with aggressive cancer features in HCC patients. Silencing of PRMT6 promoted the tumor-initiating, metastasis, and therapy resistance potential of HCC cell lines and patient-derived organoids. Consistently, loss of PRMT6 expression aggravated liver tumorigenesis in a chemical-induced HCC PRMT6 knockout (PRMT6
−/− ) mouse model. Integrated transcriptome and protein-protein interaction studies revealed an enrichment of genes implicated in RAS signaling and showed that PRMT6 interacted with CRAF on arginine 100, which decreased its RAS binding potential and altered its downstream MEK/ERK signaling. Our work describes a critical repressive function for PRMT6 in maintenance of HCC cells by regulating RAS binding and MEK/ERK signaling via methylation of CRAF on arginine 100. Graphical Abstract Highlights • PRMT6 is downregulated in HCC and correlates negatively with aggressive HCC • PRMT6 silencing drives cancer stemness in vitro and patient-derived organoids • PRMT6 binds to CRAF, methylates it, and interferes with its RAS/RAF binding • Methylation of CRAF regulates MEK/ERK-mediated cancer stemness in HCC RAS/RAF/MEK/ERK pathway signaling is known to be frequently activated in cancers, in which it regulates cell growth, malignant transformation, drug resistance, and stemness. Using hepatocellular carcinoma as a model system, Chan et al. describe a mechanism by which this oncogenic signaling pathway is regulated by PRMT6 at the post-translational level via arginine methylation. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
15. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
- Author
-
Song, Yangyang, Pan, Guangjin, Chen, Leilei, Ma, Stephanie, Zeng, Tingting, Man Chan, Tim Hon, Li, Lei, Lian, Qizhou, Chow, Raymond, Cai, Xiujuan, Li, Yan, Liu, Ming, Li, Yun, Zhu, Yinghui, Wong, Nathalie, Yuan, Yun-Fei, Pei, Duanqing, and Guan, Xin-Yuan
- Abstract
Background & Aims Levels of atonal homolog 8 ( ATOH8 ) are reduced in 48% of hepatitis B virus-associated hepatocellular carcinoma cells (HCCs). ATOH8 downregulation is associated with loss of tumor differentiation, indicating an effect mediated by cancer stem cells. We investigated the effects of loss of ATOH8 in human hepatocellular carcinoma (HCC) cells and cell lines. Methods HCC and adjacent nontumor tissues were collected, from 2001 through 2012, from 242 patients undergoing hepatectomy at Sun Yat-Sen University Cancer Center in China; 83% of HCCs were associated with hepatitis B virus (HBV) infection. CD133 + cells were isolated from tumor tissues by flow cytometry. Experiments were performed in HBV-positive and HBV-negative HCC cell lines, the immortalized liver cell line LO2, and 8 other HCC cell lines. ATOH8 was expressed from lentiviral vectors in PLC8024 and Huh7 cells; levels were knocked down with small interfering RNAs in QSG7701 cells. Cells carrying empty vectors were used as controls. Gene regulation by ATOH8 was assessed in mobility shift and luciferase reporter assays. Cells were analyzed in proliferation, foci formation, and colony formation assays. The tumorigenic and chemo-resistant potential of cells were investigated by assessing growth of xenograft tumors in immunocompromised mice. Metastatic features of cells were assessed in Matrigel invasion assays and wound healing analyses. Results Levels of ATOH8 mRNA were reduced by more than 4-fold, compared to nontumor tissues, in 118 of 242 HCC samples (48.8%). Patients with tumor reductions in ATOH8 had significantly shorter times of disease-free survival (mean, 41.4 months) than patients with normal tissue levels (mean, 52.6 months). ATOH8 expression was reduced in HepG2, Huh7, PLC8024 and CRL8064 HCC cells, as well as CD133 + cells isolated from human HCC samples. Transgenic expression of ATOH8 in HCC cell lines significantly reduced proliferation and foci colony formation, as well as their invasive and migratory abilities. Transgenic expression of ATOH8 reduced the ability of HBV-positive PLC8024 cells to form tumors in mice, compared to control cells. Cells with ATOH8 knockdown formed xenograft tumors more rapidly, in more mice, than control cells. ATOH8 repressed transcription of stem-cell associated genes including OCT4 , NANOG , and CD133 . Knockdown of ATOH8 in CD133-negative QSG7701 cells caused them to express CD133 ; acquire self-renewal, differentiation, chemo-resistance properties; form more xenograft tumors in mice; and generate induced pluripotent stem cells (based on staining for alkaline phosphatase and their ability to form embryoid bodies and teratomas). Alternatively, expression of ATOH8 in PLC8024 and Huh7 cells significantly reduced the numbers of cells expressing CD133 , and increased the chemo-sensitivity of Huh7 cells to 5-fluorouracil (5-FU) and cisplatin, in vitro and in mice. Conclusions ATOH8 appears to be a tumor suppressor that induces stem-cell features and chemoresistance in HCC cells. Strategies to restore its levels and activities might be developed to treat patients with liver cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
16. Increased Expression of EIF5A2, Via Hypoxia or Gene Amplification, Contributes to Metastasis and Angiogenesis of Esophageal Squamous Cell Carcinoma.
- Author
-
Li, Yan, Fu, Li, Li, Jian-Biao, Qin, Yanru, Zeng, Ting-ting, Zhou, Jie, Zeng, Zhao-Lei, Chen, Jinna, Cao, Ting-Ting, Ban, Xiaojiao, Qian, Chaonan, Cai, Zongwei, Xie, Dan, Huang, Peng, and Guan, Xin-Yuan
- Abstract
Background & Aims: Solid tumors often become hypoxic, leading to activation of hypoxia-response genes. We investigated the effects of overexpression of the hypoxia response genes eIF5A2 in esophageal squamous cell carcinoma (ESCC). Methods: We used quantitative real-time polymerase chain reaction and immunohistochemistry analyses to compare expression of eIF5A2 between paired ESCC samples and nontumor esophageal tissues, and fluorescence in situ hybridization to detect gene copy-number alterations. Luciferase reporter and chromatin immunoprecipitation assays were used to study interactions between eIF5A2 and hypoxia-inducible factor-1α (HIF1α). We determined the effects of eIF5A2 overexpression and knockdown in ESCC cell lines and growth of ESCC xenograft tumors in nude mice. Results: Levels of eIF5A2 messenger RNA and protein were increased in >40% of ESCC samples compared with matched nontumor tissues, along with levels of HIF1α and vascular endothelial growth factor. Increased levels of EIF5A2 were significantly associated with ESCC metastasis to lymph nodes (P < .001) and tissue invasion (P = .037), and shorter survival times of patients (P < .001). Amplification of eIF5A2 was detected in 35.14% of ESCC samples that overexpressed eIF5A2. Hypoxia increased expression of eIF5A2 4- to 8-fold in ESCC cell lines; we observed bidirectional regulation between eIF5A2 and HIF1α. Transient transfection of ESCC cell lines with eIF5A2 increased their migratory and invasive abilities and markers of the epithelial to mesenchymal transition, and eIF5A2 knockdown or HIFα inhibition reduced these. In mice, xenograft tumors grown from ESCC cells that expressed eIF5A2 formed tumors more rapidly than cells that expressed only vector (controls); they also expressed higher levels of HIF1α and vascular endothelial growth factor, and formed more microvessels than controls. Knockdown of eIF5A2 in ESCC cells with interfering RNAs reduced their growth as xenograft tumors in mice, particularly when mice were given docetaxel or cisplatin. Conclusions: eIF5A2 is overexpressed by gene amplification or hypoxia in ESCCs, and associated with up-regulation of HIF1α, metastasis, and shorter survival times of patients. Increased expression of eIF5A2 increases metastasis and angiogenesis in ESCC via the HIF1α-mediated signaling pathway. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
17. Allele-Specific Imbalance of Oxidative Stress-Induced Growth Inhibitor 1 Associates With Progression of Hepatocellular Carcinoma.
- Author
-
Liu, Ming, Li, Yan, Chen, Leilei, Man Chan, Tim Hon, Song, Yangyang, Fu, Li, Zeng, Ting–Ting, Dai, Yong–Dong, Zhu, Ying–Hui, Chen, Juan, Yuan, Yun–Fei, and Guan, Xin–Yuan
- Abstract
Background & Aims: Although there are a few highly penetrant mutations that are linked directly to cancer initiation, more less-penetrant susceptibility alleles have been associated with cancer risk and progression. We used RNA sequence analysis to search for genetic variations associated with pathogenesis of hepatocellular carcinoma (HCC). Methods: We analyzed 400 paired HCC and adjacent nontumor tissues, along with clinical information, from patients who underwent surgery at Sun Yat-Sen University in Guangzhou, China. Total RNA was extracted from tissues and sequenced, and variations with allele imbalance were identified. Effects of variants on cell functions were investigated in HCC cell lines and tumor xenografts in mice. Variants were associated with patient outcomes. Results: We found a high proportion of allele imbalance in genes related to cellular stress. A nucleotide variation in the Oxidative Stress-Induced Growth Inhibitor 1 (OSGIN1) gene (nt 1494: G–A) resulted in an amino acid substitution (codon 438: Arg–His). The variant form of OSGIN1 was specifically retained in the tumor tissues. Functional assays showed that the common form of OSGIN1 functioned as a tumor suppressor, sensitizing HCC cells to chemotherapeutic agents by inducing apoptosis. However, the variant form of OSGIN1 was less effective. It appeared to affect the translocation of OSGIN1 from the nucleus to mitochondria, which is important for its apoptotic function. The expression pattern and localization of OSGIN1 was altered in HCC specimens, compared with adjacent liver tissue. Levels of OSGIN1 messenger RNA were reduced in 24.7% of HCC specimens, and down-regulation was associated with shorter overall and disease-free survival times of patients. Patients with the OSGIN1 1494A variant had the shortest mean survival time (32.68 mo) among patient subgroups, and their tumor samples had the lowest apoptotic index. Conclusions: We identified OSGIN1 as a tumor suppressor that is down-regulated or altered in human HCCs. Variants of OSGIN1 detected in HCC samples reduce apoptosis and are associated with shorter survival times of patients. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
18. SPOCK1 Is Regulated by CHD1L and Blocks Apoptosis and Promotes HCC Cell Invasiveness and Metastasis in Mice.
- Author
-
Li, Yan, Chen, Leilei, Chan, Tim Hon Man, Liu, Ming, Kong, Kar–Lok, Qiu, Ji–Liang, Yuan, Yun–Fei, and Guan, Xin–Yuan
- Subjects
APOPTOSIS inhibition ,LIVER cancer ,LABORATORY mice ,ANIMAL models of metastasis ,DNA-binding proteins ,TRANSCRIPTION factors ,ELECTROPHORESIS ,COMPARATIVE studies - Abstract
Background & Aims: Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1L) is an SNF2-like transcription factor involved in the development of human hepatocellular carcinoma (HCC). Sparc/osteonectin, cwcv, and kazal-like domains proteoglycan 1 (SPOCK1) is up-regulated by CHD1L; we investigated its role in hepatocellular carcinogenesis. Methods: We investigated interactions between SPOCK1 and CHD1L using electrophoretic mobility shift and luciferase reporter assays. Levels of SPOCK1 messenger RNA (mRNA) and protein were measured in samples of HCC and adjacent nontumor liver tissues (135 pairs) and compared using Pearson correlation coefficients. Effects of SPOCK1 overexpression and silencing were determined in HCC cell lines (QGY-7703, PLC-8024, BEL-7402, and QGY-7701). Results: The CHD1L protein bound directly to the promoter region (nt-1662 to +34) of SPOCK1 and activated transcription. Levels of SPOCK1 mRNA and protein were increased in 60% of human HCC samples, compared with nontumor live tissues, and was associated significantly with clinical stage. Levels of SPOCK1 mRNA were increased among tumors that became metastatic, compared with those that did not, and among patients with shorter overall and disease-free survival times. Ectopic expression of SPOCK1 in HCC cells increased proliferation, foci formation, and colony formation in soft agar; these cells also formed larger xenograft tumors, more rapidly, in nude mice than control HCC cells. Silencing SPOCK1 expression with short hairpin RNA had the opposite effects. We found that SPOCK1 prevents apoptosis of HCC cells by activating Akt, to block release of cytochrome c and activation of caspase-9 and caspase-3; these effects were reversed with an Akt inhibitor. HCC cells that overexpressed SPOCK1 expressed higher levels of matrix metallopeptidase 9, were more invasive in Matrigel assays, and formed more metastatic nodules in immunodeficient mice than control HCC cells. Conclusions: CHD1L activates expression of SPOCK1, which activates Akt signaling to block apoptosis and invasion by HCC cells, in culture and in mice. Levels of SPOCK1 increase with progression of human HCC. SPOCK1 might be used as a prognostic factor or therapeutic target. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
19. Identification of PTK6, via RNA Sequencing Analysis, as a Suppressor of Esophageal Squamous Cell Carcinoma.
- Author
-
Ma, Stephanie, Bao, Jessie Y.J., Kwan, Pak Shing, Chan, Yuen Piu, Tong, Carol M., Fu, Li, Zhang, Na, Tong, Amy H.Y., Qin, Yan–Ru, Tsao, Sai Wah, Chan, Kwok Wah, Lok, Si, and Guan, Xin–Yuan
- Subjects
ESOPHAGEAL cancer ,SQUAMOUS cell carcinoma ,NUCLEOTIDE sequence ,PROTEIN-tyrosine kinases ,TUMOR suppressor genes ,CANCER cell proliferation ,GENE ontology ,IMMUNOHISTOCHEMISTRY - Abstract
Background & Aims: Esophageal squamous cell carcinoma (ESCC) is the most commonly observed histologic subtype of esophageal cancer. ESCC is believed to develop via accumulation of numerous genetic alterations, including inactivation of tumor suppressor genes and activation of oncogenes. We searched for transcripts that were altered in human ESCC samples compared with nontumor tissues. Methods: We performed integrative transcriptome sequencing (RNA-Seq) analysis using ESCC samples from 3 patients and adjacent nontumor tissues to identify transcripts that were altered in ESCC tissue. We performed molecular and functional studies of the transcripts identified and investigated the mechanisms of alteration. Results: We identified protein tyrosine kinase 6 (PTK6) as a transcript that was significantly down-regulated in ESCC tissues and cell lines compared with nontumor tissues or immortalized normal esophageal cell lines. The promoter of the PTK6 gene was inactivated in ESCC tissues at least in part via hypermethylation and histone deacetylation. Knockdown of PTK6 in KYSE30 ESCC cells using small hairpin RNAs increased their ability to form foci, migrate, and invade extracellular matrix in culture and form tumors in nude mice. Overexpression of PTK6 in these cells reduced their proliferation in culture and tumor formation in mice. PTK6 reduced phosphorylation of Akt and glycogen synthase kinase (GSK)3β, leading to activation of β-catenin. Conclusions: PTK6 was identified as a transcript that is down-regulated in human ESCC tissues via epigenetic modification at the PTK6 locus. Its product appears to regulate cell proliferation by reducing phosphorylation of Akt and GSK3β, leading to activation of β-catenin. Reduced levels of PTK6 promote growth of xenograft tumors in mice; it might be developed as a marker of ESCC. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
20. Thermal-sensitive lipid nanoparticles potentiate anti-PD therapy through enhancing drug penetration and T lymphocytes infiltration in metastatic tumor.
- Author
-
Tan, Ya-Nan, Li, Yong-Peng, Huang, Jian-Dong, Luo, Min, Li, Shan-Shan, Lee, Anne Wing-Mui, Hu, Fu-Qiang, and Guan, Xin-Yuan
- Subjects
- *
CYTOTOXIC T cells , *CATIONIC lipids , *LIPIDS , *TUMOR-infiltrating immune cells , *T cell receptors , *TUMORS , *METASTASIS , *THERAPEUTICS - Abstract
The response rate of anti-PD therapy in most cancer patients remains low. Therapeutic drug and tumor-infiltrating lymphocytes (TILs) are usually obstructed by the stromal region within tumor microenvironment (TME) rather than distributed around tumor cells, thus unable to induce the immune response of cytotoxic T cells. Here, we constructed the cationic thermosensitive lipid nanoparticles IR780/DPPC/BMS by introducing cationic NIR photosensitizer IR-780 iodide (IR780) modified lipid components, thermosensitive lipid DPPC and PD-1/PD-L1 inhibitor BMS202 (BMS). Upon laser irradiation, IR780/DPPC/BMS penetrated into deep tumor, and reduced cancer-associated fibroblasts (CAFs) around tumor cells to remodel the spatial distribution of TILs in TME. Interestingly, the cationic IR780/DPPC/BMS could capture released tumor-associated antigens (TAAs), thereby enhancing the antigen-presenting ability of DCs to activate cytotoxic T lymphocytes. Moreover, IR780/DPPC/BMS initiated gel-liquid crystal phase transition under laser irradiation, accelerating the disintegration of lipid bilayer structure and leading to the responsive release of BMS, which would reverse the tumor immunosuppression state by blocking PD-1/PD-L1 pathway for a long term. This combination treatment can synergistically exert the antitumor immune response and inhibit the tumor growth and metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. C-terminal truncated HBx protein activates caveolin-1/LRP6/β-catenin/FRMD5 axis in promoting hepatocarcinogenesis.
- Author
-
Mao, Xiaowen, Tey, Sze Keong, Ko, Frankie Chi Fat, Kwong, Ernest Man Lok, Gao, Yi, Ng, Irene Oi-Lin, Cheung, Siu Tim, Guan, Xin-Yuan, and Yam, Judy Wai Ping
- Subjects
- *
HEPATITIS B , *THERAPEUTICS , *PROTEINS - Abstract
Hepatitis B virus X protein mutants, particularly truncated at C-terminal (HBxΔC), generated during random viral integration, are frequently detected in hepatocellular carcinoma (HCC) and exert a more potent oncogenic effect than full-length form (FL). Here, we showed that caveolin-1 (Cav1), a robust metastasis promoter, is transcriptionally upregulated by HBxΔC but not by FL HBx. Promoting effect of HBxΔC in HCC cell aggressiveness is abolished when Cav1 is suppressed. Expression profiling identified FERM domain containing 5 (FRMD5) protein as a downstream target of Cav1. In accordance with the regulation of Cav1, HBxΔC upregulates FRMD5. Knockdown of FRMD5 in HBxΔC cells recapitulated the functional effect of Cav1 knockdown in HBxΔC cells. The regulation of FRMD5 by HBxΔC-induced Cav1 is mediated by the protein stablilization of LRP6 leading to the activation of β-catenin. Expression of a constitutively active β-catenin in Cav1 knockdown cells rescued FRMD5 expression and HCC tumorigenesis and metastasis. Clinical relevance of HBxΔC/Cav1/LRP6/FRMD5 pathway is demonstrated by the significant correlation of Cav1, LRP6 and FRMD5 expressions in HCC. The findings of this study uncover a novel HBxΔC-regulated molecular pathway which has profound implications in HCC therapeutics. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
22. ApoA-1 accelerates regeneration of small-for-size fatty liver graft after transplantation.
- Author
-
Li, Chang Xian, Chen, Lei Lei, Li, Xiang Cheng, Ng, Kevin Tak-Pan, Yang, Xin Xiang, Lo, Chung Mau, Guan, Xin Yuan, and Man, Kwan
- Subjects
- *
FATTY liver , *APOLIPOPROTEIN A , *APOLIPOPROTEIN genetics , *METABOLISM , *LIVER abnormalities - Abstract
Abstract Objectives Apolipoprotein A-1 (ApoA-1) is involved in regulating both lipid and energy metabolism, which may play important roles in liver regeneration, especially for the liver with steatosis. We here intended to investigate the role of ApoA-1 in regeneration of small-for-size fatty liver graft and to explore the underlying mechanism. Methods The association of ApoA-1 expression with liver regeneration was studied in rat liver transplantation models using small-for-size normal graft or small-for-size fatty graft. The direct role of ApoA-1 in liver regeneration was studied in mouse hepatectomy model in vivo and hepatocytes in vitro. Results Compared to small-for-size normal graft, decreased expression of ApoA-1 associated with delayed regeneration were detected in small-for-size fatty liver graft after transplantation. In functional study, the expression of ApoA-1 was decreased in hepatocytes with steatosis and was inversely associated with the concentration of oleic acid. The ApoA-1 administration effectively attenuated hepatocytes steatosis and accelerated hepatocytes proliferation. In mouse model, ApoA-1 treatment promoted liver regeneration at day 2 after major hepatectomy. In addition, the treatment of ApoA-1 increased the expressions of PGC-1α and its target genes Tfam, Ucp2 and SDHB. Conclusions ApoA-1 may accelerate regeneration of small-for-size fatty liver graft at day 2 after transplantation through regulating mitochondrial function. ApoA-1 may be the potential new therapy of promoting liver regeneration. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
23. SEI1 induces genomic instability by inhibiting DNA damage response in ovarian cancer.
- Author
-
You, Jia, Liu, Jia, Bao, Yantao, Wang, Liqun, Yu, Yang, Wang, Lei, Wu, Di, Liu, Chang, Wang, Nan, Wang, Fei, Wang, Falin, Xu, Lu, Tian, Xing, Liang, Hongbin, Gao, Yating, Guan, Rongwei, Bai, Jing, Meng, Xiangning, Sun, Wenjing, and Guan, Xin-Yuan
- Subjects
- *
NUCLEIC acids , *ONCOLOGY , *DNA damage , *BIOCHEMICAL genetics , *OVARIAN cancer , *PROTEIN metabolism , *BIOCHEMISTRY , *BIOLOGICAL transport , *CALCIUM-binding proteins , *CELL lines , *CELLULAR signal transduction , *DNA , *GENES , *GENETIC techniques , *PHENOMENOLOGY , *GENETIC mutation , *OVARIAN tumors , *PHOSPHORYLATION , *PROTEIN kinases , *PROTEINS , *TUMOR classification , *NUCLEAR proteins - Abstract
Previous studies have shown that the oncogene SEI1 is highly expressed in ovarian carcinomas, and promoting genomic instability. However, the molecular mechanism of SEI1 in promoting genomic instability remains unclear. We observed SEI1 overexpression in 30 of 46 cases of ovarian cancer compared to non-tumor tissues and the overexpression of SEI1 was positively associated with the tumor FIGO stage. Our functional studies revealed that overexpression of SEI1 could induce genomic instability and increased DNA strand breaks. In contrast, SEI1 co-localized with γH2AX and phosphorylated ATM and DNAPKcs in the nucleus. Furthermore, we found that overexpression of SEI1 induced translocation of the SEI1 protein from the cytoplasm to the nucleus; ATM and DNAPKcs were associated with the cytoplasm-to-nucleus translocation of SEI1. To further prove the correlation between the DNA damage response (DDR) and SEI1, we knocked down SEI1 expression in SEI1-transfected ovarian cancer cell lines. The expression of DDR proteins was significantly downregulated, and the number of micronuclei was significantly decreased. Together, these results define a new mechanism of SEI1 in the regulation of genomic stability and in the malignant progression of ovarian cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
24. Cancer stem cells: Recent insights and therapies.
- Author
-
Zhou, Hongyu, Tan, Licheng, Liu, Beilei, and Guan, Xin-Yuan
- Subjects
- *
CANCER stem cells , *STEM cell niches , *TUMOR microenvironment - Abstract
[Display omitted] Tumors are intricate ecosystems containing malignant components that generate adaptive and evolutionarily driven abnormal tissues. Through self-renewal and differentiation, cancers are reconstructed by a dynamic subset of stem-like cells that enforce tumor heterogeneity and remodel the tumor microenvironment (TME). Through recent technology advances, we are now better equipped to investigate the fundamental role of cancer stem cells (CSCs) in cancer biology. In this review, we discuss the latest insights into characteristics, markers and mechanism of CSCs and describe the crosstalk between CSCs and other cells in TME. Additionally, we explore the performance of single-cell sequencing and spatial transcriptome analysis in CSCs studies and summarize the therapeutic strategies to eliminate CSCs, which could broaden the understanding of CSCs and exploit for therapeutic benefit. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. Hepatocellular carcinoma: Transcriptome diversity regulated by RNA editing.
- Author
-
Li, Yan, Chen, Leilei, Chan, Tim Hon Man, and Guan, Xin-Yuan
- Subjects
- *
LIVER cancer , *RNA editing , *EPIGENETICS , *MOLECULAR pathology , *GENETIC transcription , *CELL transformation , *CANCER cells - Abstract
Abstract: Hepatocellular carcinoma (HCC) can be envisioned as a prolonged multi-stage process accumulating genetic and epigenetic changes. In the past years, DNA alterations lent us important clues to the comprehension of molecular pathways involved in HCC. However, as an increasing number of RNAs were identified to be subject to A-to-I modifications, it has become apparent that RNA editing might be the causal basis of various human diseases. Recent evidence has strengthened this notion by correlating hyper-edited AZIN1 (antizyme inhibitor 1) protein with HCC onset and the mechanisms that regulate cell transformation. As we continue to demystify it, RNA editing astonishes us with its diverse substrates, esoteric functions, elaborate machinery and complex interaction with HBV/HCV viral infection. In this review, we examine the contribution of A-to-I RNA editing to caner onset/progression and explore its potential implications for cancer treatment advances. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
26. Spatholobus suberectus inhibits cancer cell growth by inducing apoptosis and arresting cell cycle at G2/M checkpoint
- Author
-
Wang, Zhi-Yu, Wang, Dong-Mei, Loo, Tjing Yung, Cheng, Yue, Chen, Lei-Lei, Shen, Jian-Gang, Yang, De-Po, Chow, Louis Wing-Cheong, Guan, Xin-Yuan, and Chen, Jian-Ping
- Subjects
- *
MEDICINAL plants , *REACTIVE oxygen species , *ALTERNATIVE medicine , *ANALYSIS of variance , *ANIMAL experimentation , *ANTINEOPLASTIC agents , *APOPTOSIS , *BIOPHYSICS , *BREAST tumors , *COLON tumors , *DOSE-effect relationship in pharmacology , *FLOW cytometry , *RESEARCH methodology , *MICE , *STAINS & staining (Microscopy) , *STATISTICAL hypothesis testing , *T-test (Statistics) , *WESTERN immunoblotting , *PLANT extracts , *PHARMACODYNAMICS - Abstract
Abstract: Aim of the study: Although herbs have long been alternatively applied for cancer treatment in China, its treatment effects and their potential mechanisms have not been sufficiently investigated. The chinese herb Spatholobus suberectus (SS) is commonly prescribed to cancer patients. In this study, the anti-cancer effect of SS and its molecular mechanisms have been investigated. Materials and methods: The effect of SS on cell proliferation was studied by cell growth assay and flow cytometry on breast cancer cell lines MCF-7 and colon cancer cell line HT-29. The role of SS in apoptosis was studied by flow cytometry, DNA fragmentation assay and mitochondrial membrane potential assay. Expression of proteins associated with cell cycle and apoptosis was determined by Western blot analysis. The in vivo effect of SS was tested in nude mouse cancer xenografts. Results: Cell growth assay showed that SS effectively inhibits tumor cell growth in a dose-dependent manner. Flow cytometry analysis showed that SS could arrest the cell cycle at G2/M checkpoint, which is associated with DNA damage and activation of phosphor-Chk1/Chk2. The pro-apoptotic effect of SS was demonstrated by Annexin V-PI staining and mitochondrial membrane potential assay. In vivo experiments show that the efficiency of SS alone group was superior to docetaxel or to docetaxel and SS combined. No obvious body weight loss or blood toxicity was observed in SS tested animals. Conclusions: Our data demonstrates that SS is a potential herb for cancer treatment by inhibiting tumor growth via induction of apoptosis and arrest of the cell cycle at G2/M phase. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
27. Functional dissection of an IFN-α/β receptor 1 promoter variant that confers higher risk to chronic hepatitis B virus infection
- Author
-
Zhou, Jie, Huang, Jian-Dong, Poon, Vincent K.M., Chen, Ding-Qiang, Chan, Chris C.S., Ng, Fai, Guan, Xin-Yuan, Watt, Rory M., Lu, Liwei, Yuen, Kwok-Yung, and Zheng, Bo-Jian
- Subjects
- *
INTERFERONS , *CELL receptors , *HEPATITIS B , *PROMOTERS (Genetics) , *GENETIC polymorphisms , *DISEASE susceptibility , *PROTEIN binding , *RNA polymerases , *GENE expression , *GENETICS - Abstract
Background/Aims: We previously demonstrated that two linked single nucleotide polymorphisms (SNPs) at −408 and −3 of type I interferon receptor 1 (IFNAR1) promoter are associated with susceptibility to chronic HBV infection. We aimed to elucidate the mechanism by which −3 and/or −408 C/T SNPs had such profound effects. Methods: A functional SNP in IFNAR1 promoter was defined by reporter gene assay, mutational analysis, flow cytometry analysis and gel shift assay. The nuclear protein binding to the essential polymorphic site was identified and its effect on transcriptional regulation of IFNAR1 was further demonstrated in a series of ex vivo and in vivo experiments. Results: We found C>T change at the −3 locus reduced the transcriptional activity of IFNAR1 promoter. High mobility group B protein 1 (HMGB1) and PARP-1 were co-recruited to the IFNAR1 promoter to regulate its transcription. We demonstrated HMGB1-binding affinity to IFNAR1 promoter was reduced in the −3T variant. Additionally, PARP-1, a cofactor for IFNAR1 transcription activation, was significantly suppressed by HBV. Conclusion: Upon HBV infection, decreased binding affinity of HMGB1 to the IFNAR1 promoter −3T variant is aggravated by the suppressed PARP-1 expression caused by HBV, resulting in a further attenuated IFNAR1 expression. This compromises the antiviral and immuno-regulatory effects of IFN-α/β, which may in turn affect the clinical outcome of HBV infection. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
28. Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma
- Author
-
Lee, Terence K., Poon, Ronnie T.P., Man, Kwan, Guan, Xin-Yuan, Ma, Stephanie, Liu, Xiao Bing, Myers, Jeffrey N., and Yuen, Anthony P.W.
- Subjects
- *
CANCER prognosis , *CANCER invasiveness , *SQUAMOUS cell carcinoma , *CANCER patients - Abstract
Abstract: Oral squamous cell carcinoma (OSCC) is associated with a high potential of tumor recurrence and metastasis, leading to poor prognosis. Cell motility is an important factor in the progression and metastasis of cancers. Recently, Fascin has been linked to tumor progression by induction of cell motility. However, the precise roles of Fascin in OSCC have not been elucidated clearly. The aim of this study was to analyze the roles of Fascin in OSCC progression using OSCC clinical samples. We demonstrated that Fascin over-expression was found in OSCC clinical samples and its expression was significantly associated with nodal metastasis (p =0.027), tumor recurrence (p <0.001) and poor patients’ overall survival (p =0.013). Consistently, Fascin proteins were detected in all OSCC cell lines with the expression level corresponding to the invasion ability. To specifically investigate the mechanism of Fascin in OSCC, we examined the E-cadherin expression in the same set of OSCC specimens. Fascin was negatively correlated with E-cadherin expression (p =0.018, r =−0.513). In conclusion, our findings suggested that Fascin over-expression might enhance OSCC aggressiveness, possibly by interacting with E-cadherin expression. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
29. Up-regulation of fibroblast growth factor 3 is associated with tumor metastasis and recurrence in human hepatocellular carcinoma
- Author
-
Hu, Liang, Sham, Jonathan S.T., Xie, Dan, Wen, Jian-Ming, Wang, Wei-Sheng, Wang, Yi, and Guan, Xin-Yuan
- Subjects
- *
CELL lines , *CHROMOSOMES , *CYTOGENETICS , *NUCLEOTIDE sequence - Abstract
Abstract: Recently, we established a hepatocellular carcinoma (HCC) cell line (named H4-M) from a metastatic HCC tumor. In H4-M, a marker chromosome containing a homogeneously staining region (hsr) was identified by cytogenetic analysis. The hsr was characterized by chromosome microdissection and the result showed that the hsr was composed of DNA sequence from 11q13. Oncogenes CCND1 and FGF3 were localized within the complicon and overexpressions of CCND1 and FGF3 were confirmed by Northern blot analysis. Clinical significance of FGF3 overexpression was studied by immunohistochemistry (IHC) using an HCC tissue microarray (TMA) containing 60 pairs of primary/metastatic HCCs and 30 pairs of primary/recurrent HCCs. TMA study showed that overexpression of FGF3 was significantly associated with HCC metastasis and recurrence , suggesting that up-regulation of FGF3 may play an important role in HCC metastasis and recurrence. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
30. Characterization of rearrangements involving 4q, 13q and 16q in hepatocellular carcinoma cell lines using region-specific multiplex-FISH probes
- Author
-
Tjia, Wai Mui, Hu, Liang, Zhang, Min-Yue, and Guan, Xin-Yuan
- Subjects
- *
LIVER cancer , *CELL lines , *CELL culture , *CELL nuclei - Abstract
Abstract: Deletions in 4q, 13q and 16q were frequently detected in hepatocellular carcinoma (HCC) by comparative genomic hybridization (CGH) studies. However, detailed chromosome structural aberrations are not fully explored. Using CGH combined with multiplex-color FISH (M-FISH) with chromosome region-specific probes (CRPs), chromosome structural aberrations in 4q, 13q and 16q in six HCC cell lines were studied. All CRPs, which were generated from microdissected DNA, were specific, strong in intensity and sensitive enough to detect chromosome structural aberrations including translocation and deletion. FISH with BAC probes was used to further characterize translocation breakpoints and deletions. A breakpoint at 16q22 was localized at a BAC clone (RP11-341K23) and another breakpoint at 4q28 was localized within a 620kb-region. A minimal deleted region at 13q21 was found between BAC clones RP11-240M20 and RP11-435P18. This study demonstrated that the combination of CGH, M-FISH and BAC-FISH is a very useful tool to detect and characterize translocation breakpoint. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
31. SRC-3/AIB1 protein and gene amplification levels in human esophageal squamous cell carcinomas
- Author
-
Xu, Fang-Ping, Xie, Dan, Wen, Jian-Ming, Wu, Hui-Xi, Liu, Yong-Dong, Bi, Jiong, Lv, Zhi-Li, Zeng, Yi-Xin, and Guan, Xin-Yuan
- Subjects
- *
SQUAMOUS cell carcinoma , *CELL proliferation , *IMMUNOHISTOCHEMISTRY , *CANCER invasiveness - Abstract
Abstract: It has been suggested that the steroid receptor coactivatior-3 (SRC-3) gene, also known as AIB1, ACTR, RAC3, p/CIP and TRAM-1, located at 20q12, plays an oncogenic role in several types of human cancers. In this study, we examined the encoded protein expression of SRC-3 and its copy number in 221 human esophageal squamous cell carcinomas (ESCCs). In this ESCC series, the overexpression and increased copy number of SRC-3 gene was detected in 46 and 13% of ESCCs, respectively. In addition, overexpression of SRC-3 was observed more frequently in primary ESCCs in late T stages (T3/T4) than that in earlier T1/T2 stages (P<0.05), but no significant association of expression of SRC-3 and status of lymph node metastases was observed (P>0.05). These results suggest that overexpression of SRC-3, caused by gene amplification/gain or other molecular mechanisms, might provide a selective advantage for the development and local invasion of certain subsets of ESCC. In addition, a significant correlation (P<0.05) of overexpression of SRC-3 with increased cell proliferation (through detection of Ki-67 expression) was observed in these ESCCs. These findings suggest a potential role of SRC-3 in the control of ESCC cell proliferation; such may be responsible, at least in part, for tumorigenesis and/or progression of ESCC. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
32. Characterization of 3p, 5p, and 3q in two nasopharyngeal carcinoma cell lines, using region-specific multiplex fluorescence in situ hybridization probes
- Author
-
Tjia, Wai Mui, Sham, Jonathan S.T., Hu, Liang, Tai, Amy L.S., and Guan, Xin-Yuan
- Subjects
- *
CANCER , *FLUORESCENCE , *IN situ hybridization , *NUCLEIC acids - Abstract
Abstract: Amplification of chromosome arms 3q and 5p and deletion of 3p were frequently detected in nasopharyngeal carcinoma (NPC) with comparative genomic hybridization and loss of heterozygosity studies. To identify the minimal amplified or deleted regions in these arms, structural aberrations in chromosome arms 3p, 3q, and 5p in two NPC cell lines, CNE1 and SUNE1, were studied with multiplex-color FISH (M-FISH) and chromosome region-specific probes (CRP). All CRPs, which were generated from microdissected DNA, were specific and strong in intensity, and sensitive enough to detect chromosome aberrations including translocations, deletions, and amplifications of target regions. In these two NPC cell lines, minimal regions of deletion and amplification were found at 3p12 and 3q26∼q27, respectively. On 5p, most of the regions were amplified as intact copies. Interregion translocations of these three arms were also observed. The amplification on 3q26∼q27 provided useful hints for further screening the minimal amplification at RP11-115J24 (3q26.2), containing candidate oncogene eIF-5A2. M-FISH with CRPs is thus not only useful in revealing a comprehensive picture of structural aberrations in target chromosomes, but also in narrowing down the minimal region for screening cancer-related genes. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
33. Establishment of cell lines from a primary hepatocellular carcinoma and its metastatis
- Author
-
Hu, Liang, Wen, Jian-Ming, Sham, Jonathan S.T., Wang, Weisheng, Xie, Dan, Tjia, Wai Mui, Huang, Jie-Fu, Zhang, Meng, Zeng, Wei-Fen, and Guan, Xin-Yuan
- Subjects
- *
LIVER cancer , *PROGNOSIS , *METASTASIS , *CELL lines - Abstract
Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world with a very poor prognosis that has been associated with tumor metastasis. The molecular mechanism of HCC metastasis is still unclear. In this study, we established cell lines from a primary tumor (H2-P) and its metastatis (H2-M). G-banding karyotyping, comparative genomic hybridization, and fluorescence in situ hybridization were applied to study these two cell lines and the results demonstrated that they are of the same origin. These cell lines provide a very useful tool to identify genetic alterations associated with HCC metastasis. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
34. Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients
- Author
-
He, Qiao-Jie, Zeng, Wei-Fen, Sham, Jonathan S.T., Xie, Dan, Yang, Xing-Wu, Lin, Han-Liang, Zhan, Wen-Hua, Lin, Feng, Zeng, Sui-De, Nie, Daping, Ma, Lin-Fei, Li, Chu-Jun, Lu, Shen, and Guan, Xin-Yuan
- Subjects
- *
COLON cancer - Abstract
Colorectal cancer (CRC) is one of the most common malignancies worldwide. The incidence of CRC in the Chinese population has increased dramatically during the last two decades; however, nonrandom chromosomal alterations in Chinese patients have not been described. In the present study, comparative genomic hybridization (CGH) was applied to detect recurrent chromosome alterations in 26 primary colorectal carcinomas and 21 colorectal adenomas from Chinese patients. In CRC, several recurrent chromosomal changes were found, including gains of 8q (14/26 cases, 54%), 20q (54%), 3q (50%), 13q (50%), 5p (46%), 7p (42%), 7q (42%), and 12p (38%) and losses of 18q (65%) and 17p (42%). From comparison with previous CGH studies, the frequent gains of 3q and 12p might be distinctive occurrences in Chinese patients. The distribution of frequently found chromosomal alterations in different locations was studied. The gain of 20q was more frequently found in colon cancer (P<0.01) and the gain of 12p was more frequently found in rectal cancer. Chromosomal alterations were found in 19/21 of adenomas; the most frequent chromosomal alteration was the loss of 18q (9/21 cases, 43%). These recurrent alterations provide several starting points for the isolation of candidate oncogenes and tumor suppressor genes. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
35. Establishment and characterization of human metastatic hepatocellular carcinoma cell line
- Author
-
Wen, Jian-Ming, Huang, Jie-Fu, Hu, Liang, Wang, Wei-Sheng, Zhang, Meng, Sham, Jonathan S.T., Xu, Jian-Min, Zeng, Wei-Fen, Xie, Dan, Liang, Li-Jian, and Guan, Xin-Yuan
- Subjects
- *
LIVER cancer , *CHROMOSOME abnormalities , *TUMOR markers - Abstract
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide with a poor prognosis. Recently, we established a HCC cell line from a metastatic HCC tumor. GTG banding analysis was performed and the karyotype showed that this metastatic HCC cell line is a hypertriploid (71–78 chromosomes) with a large marker chromosome containing a long homogeneously staining region (hsr). Comparative genomic hybridization was applied to characterize the chromosomal alterations in this metastatic HCC cell line. The results showed that the hsr was composed of amplified DNA sequences from 11q13. Further characterization of the hsr may lead to the isolation of the putative amplified oncogene at 11q13. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
36. Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women
- Author
-
Sham, Jonathan S.T., Tang, Terence C.-M., Fang, Yan, Sun, Li, Qin, Lun-Xiu, Wu, Qiu-Liang, Xie, Dan, and Guan, Xin-Yuan
- Subjects
- *
OVARIAN tumors , *CANCER in women , *CHROMOSOME abnormalities , *GENETICS - Abstract
Ovarian cancer is one of the most frequent gynecological malignancies worldwide with a poor prognosis. Comparative genomic hybridization has been applied to detect recurrent chromosome alterations in 31 primary ovarian carcinomas in Chinese women. Several nonrandom chromosomal changes were identified including gains of 3q (17 cases, 55%) with a minimum region at 3q25∼q26, 8q (16 cases, 52%), 19q (12 cases, 39%), Xq (11 cases, 35%), 1q (10 cases, 32%), 12p12∼q13 (10 cases, 32%), 17q (10 cases, 32%) with a minimum gain region at 17q21, and 20q (9 cases, 29%); and losses of 16q (9 cases, 29%), 1p (7 cases, 23%), 18q (7 cases, 23%), and 22 (7 cases, 23%). High-copy-number amplification was detected in eleven cases. Amplification of 3q25∼q26 was detected in four cases, and amplifications of 8q24 and 12p11.2∼q12 were observed in three cases each. The recurrent gains and losses of chromosomal regions identified in this study provide candidate regions that may contain oncogenes or tumor suppressor genes involved in the development and progression of ovarian cancer. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
37. Corrigendum to “Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma” [J Hepatol 2015;62:607–616].
- Author
-
Yeung, Oscar W.H., Lo, Chung-Mau, Ling, Chang-Chun, Qi, Xiang, Geng, Wei, Li, Chang-Xian, Ng, Kevin T.P., Forbes, Stuart J., Guan, Xin-Yuan, Poon, Ronnie T.P., Fan, Sheung-Tat, and Man, Kwan
- Subjects
- *
MACROPHAGES , *TUMOR growth , *LIVER cancer - Abstract
A correction to the article "Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma," that was published in the 2015 issue is presented.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.